PERT for pancreatic enzyme insufficiency in pancreatic cancer
Part of Cancer, Digestive system clinical trials.
This trial tests if a pancreatic enzyme replacement therapy (PERT) helps weight loss caused by tumors in the head of the pancreas. It may improve nutrition for people with advanced pancreatic cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have pancreatic cancer that cannot be removed by surgery, or has spread to nearby areas or other parts of the body.
- Your tumor is in the head of the pancreas.
- Your main pancreatic duct is widened, seen on a CT scan, MRI, or endoscopic ultrasound.
- You have lost at least 5% of your usual body weight recently.
- You have not had this type of enzyme therapy before.
- You have not had surgery on your upper digestive tract or pancreas.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether pancreatic enzyme replacement therapy (PERT) helps patients with severe acute pancreatitis who have significant pancreatic damage and weight loss. The treatment may improve digestion and help regain weight.
This trial tests whether a pancreatic enzyme replacement therapy (PERT) can help people who still have digestive problems after a recent episode of acute pancreatitis. The goal is to see if it improves symptoms like stomach pain, bloating, or diarrhea.
This study tests a new pancreatic enzyme medicine (called NHS7108) for people with exocrine pancreatic insufficiency (EPI). EPI means your pancreas doesn't make enough enzymes to break down food properly. The study aims to see if this new medicine is safe and works well to help your body absorb nutrients.
This trial tests a new blood test to measure how well your pancreas works. It may help people with chronic pancreatitis understand their condition and quality of life.
This study uses small pancreatic cancer samples grown in the lab to understand which treatments may work best for people with pancreatic cancer. It may help researchers better “profile” tumors so standard care can be matched to the most effective options.
This trial tests whether enzymes from microbes work as well as enzymes from pigs to help people with chronic pancreatitis digest food better. It aims to find a treatment that reduces symptoms like pain and poor digestion.
Hear when a new Unresectable Pancreatic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.